& Blog
Meet us at DIHAD
Retirement of Mr. Shree Rajwade
Meeting with MOHAP UAE
Closing anniversary year with successful event in Mumbai
Shipping emergency health goods to Afghanistan
Wrapping up a special year
Climate change impacts global health
IDA receives ISO 14001:2015 certificate
Outcomes of collaborative Malaria RDT sustainability study available
Investing in gender equality
WHO prequalifies heat-stable carbetocin for PPH prevention
Increasing access to nursing supplies in LMICs
Joining forces to ensure emergency shipments to Ukraine
Building local presence: partnering with manufacturers in destination countries
Improving access to pyrantel to treat worm infections in children
Supply Chain & Logistics update
Ukraine logistics update
Invitation to bid (ITB) on behalf of Stop TB/GDF
Supporting healthy pregnancies with MMS
Guidance: Ordering pharmaceutical products for Ukraine
Ukraine logistics update
IDA Product Indicator 2022 now available
Improving access to assistive technologies in LMICs
Innovative partnership to increase supply chain efficiency
Michiel de Goeje retires, Bart van Osch new QA Director
An exciting year ahead
Reaching children with paediatric kits
More cancer treatment on new WHO EML
Emergency response: essential kits for Afghanistan
Reducing maternal mortality in LMICs
Over 200 pallets with kits shipped to Afghanistan
Expanding our vaccination and immunisation portfolio
IDA adds MMS to maternal health portfolio
IDA supports Mumbai hospitals with oxygen concentrators
Invitation to bid (ITB) on behalf of Stop TB/GDF
New animated IDA kitting video
Immediate availability: dexamethasone injection to treat severe cases of COVID-19
Partnership with Pfizer expands access to cancer treatments in 70 LMICs
Free shipping until the end of the year
Invitation to Bid (ITB) on behalf of Stop TB/GDF
Partnership with ADB for the supply of PPE in Asia
Price reduction of bedaquiline in the fight against TB
Corona virus (COVID-19) outbreak - FAQ
IDA's first Communication on Engagement published
Responding to the corona virus
Award for IDA’s Ethics & Compliance Advisor
First all-oral, 6-months treatment for highly resistant forms of DR-TB available
Strengthened PPM Vector Control programme
ITB for tuberculosis drugs
La 49 ème Conférence mondiale sur la santé respiratoire

Items 1 to 50 of 51 total

51 Items